HDST-M Stock Overview
Operates in the biotechnology industry in Israel. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
HBL - Hadasit Bio-Holdings Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₪0.51 |
| 52 Week High | ₪0.88 |
| 52 Week Low | ₪0.19 |
| Beta | 0.68 |
| 1 Month Change | 9.66% |
| 3 Month Change | 98.83% |
| 1 Year Change | 2.20% |
| 3 Year Change | -86.33% |
| 5 Year Change | -85.89% |
| Change since IPO | -99.82% |
Recent News & Updates
Shareholder Returns
| HDST-M | IL Biotechs | IL Market | |
|---|---|---|---|
| 7D | -0.8% | -0.6% | -0.5% |
| 1Y | 2.2% | -24.8% | 23.0% |
Return vs Industry: HDST-M exceeded the IL Biotechs industry which returned -24.8% over the past year.
Return vs Market: HDST-M underperformed the IL Market which returned 23% over the past year.
Price Volatility
| HDST-M volatility | |
|---|---|
| HDST-M Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 4.9% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in IL Market | 8.0% |
| 10% least volatile stocks in IL Market | 3.0% |
Stable Share Price: HDST-M's share price has been volatile over the past 3 months compared to the IL market.
Volatility Over Time: Insufficient data to determine HDST-M's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 2 | Yoram Azulai | www.hbl.co.il |
HBL - Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It operates in the fields of oncology, regenerative medicine, and inflammatory disease. The company develops biological drugs; and plasma RNA biomarkers for colorectal cancer.
HBL - Hadasit Bio-Holdings Ltd Fundamentals Summary
| HDST-M fundamental statistics | |
|---|---|
| Market cap | ₪5.67m |
| Earnings (TTM) | -₪7.66m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.7x
P/E RatioIs HDST-M overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HDST-M income statement (TTM) | |
|---|---|
| Revenue | ₪0 |
| Cost of Revenue | ₪0 |
| Gross Profit | ₪0 |
| Other Expenses | ₪7.66m |
| Earnings | -₪7.66m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.69 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 59.0% |
How did HDST-M perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 07:20 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
HBL - Hadasit Bio-Holdings Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|